Complement Pathways in Membranous Nephropathy: Complex and Multifactorial

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial

Bibliographic Details
Main Authors:	Vesna Brglez, Sonia Boyer-Suavet, Barbara Seitz-Polski
Format:	Article
Language:	English
Published:	Elsevier 2020-05-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024920311074

Similar Items

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2021-10-01)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2022-05-01)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2021-04-01)

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
by: Marion Cremoni, et al.
Published: (2020-11-01)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
by: Sonia Boyer-Suavet, et al.
Published: (2020-01-01)

The classical pathway triggers pathogenic complement activation in membranous nephropathy
by: Larissa Seifert, et al.
Published: (2023-01-01)

Lectin complement pathway and diabetes mellitus in the pathogenesis of membranous nephropathy
by: Irina Y. Zdravkova, et al.
Published: (2023-08-01)

Alternative pathway dysregulation and the conundrum of complement activation by IgG4 immune complexes in membranous nephropathy
by: Dorin-Bogdan eBorza
Published: (2016-04-01)

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
by: Aishwarya Ravindran, et al.
Published: (2020-05-01)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
by: Matthieu Buscot, et al.
Published: (2023-03-01)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
by: Caroline Ruetsch, et al.
Published: (2021-01-01)

Modern view on the complement system role in membranous nephropathy
by: Elena S. Kamyshova, et al.
Published: (2022-08-01)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
by: Wentian Luo, et al.
Published: (2018-06-01)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
by: Céline Occelli, et al.
Published: (2022-09-01)

Predicting diabetic nephropathy using a multifactorial genetic model.
by: Ilana Blech, et al.
Published: (2011-01-01)

Complement activation products in the circulation and urine of primary membranous nephropathy
by: Mu-fan Zhang, et al.
Published: (2019-08-01)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
by: Isabelle Ayoub, et al.
Published: (2021-02-01)

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
by: Sabrina Manni, et al.
Published: (2023-03-01)

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
by: Michael Levraut, et al.
Published: (2022-03-01)

Complement System and C4d expression in cases of Membranous nephropathy
by: Fabiano Bichuette Custódio, et al.

Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction
by: Hui Wang, et al.
Published: (2022-03-01)

Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
by: Woong Na, et al.
Published: (2017-01-01)

Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study
by: Li J, et al.
Published: (2023-05-01)

Complement Activation in Patients With Diabetic Nephropathy
by: Pascal Bus, et al.
Published: (2018-03-01)

NEPHROPATHIES ASSOCIATED WITH COMPLEMENT SYSTEM PATHOLOGY
by: V. V. Dlin, et al.
Published: (2017-01-01)

Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy
by: Shimin Jiang, et al.
Published: (2022-04-01)

Orbitomaxillofacial Mucormycosis Requiring Complex Multifactorial Management
by: Anna K. Steve, MD, et al.
Published: (2018-10-01)

The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy
by: Pallavi Manral, et al.
Published: (2022-07-01)

Patient-Level Evaluation of Community-Based, Multifactorial Intervention to Prevent Diabetic Nephropathy in Northern Alberta, Canada
by: John-Michael Gamble, et al.
Published: (2012-04-01)

The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets
by: Benjamin Y. F. So, et al.
Published: (2022-10-01)

Editorial: Immune dysfunction in nephrotic syndrome - recent advances and new roads ahead
by: Barbara Seitz-Polski, et al.
Published: (2022-08-01)

Complement Activation Is Associated With Crescents in IgA Nephropathy
by: Zi Wang, et al.
Published: (2021-09-01)

Activation of complement system by mannan pathway and Mbl2 genotypes in patients with type 2 diabetes and nephropathy
by: Tjaša Cerar, et al.
Published: (2014-11-01)

M2 Macrophage Subpopulations in Glomeruli Are Associated With the Deposition of IgG Subclasses and Complements in Primary Membranous Nephropathy
by: Wenxue Hu, et al.
Published: (2021-05-01)

Membranous nephropathy
by: Márcio Dantas, et al.
Published: (2023-07-01)

Multifactorial engineering of biomimetic membranes for batteries with multiple high-performance parameters
by: Mingqiang Wang, et al.
Published: (2022-01-01)

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
by: Marion Cremoni, et al.
Published: (2022-09-01)

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy
by: Karyne Pelletier, et al.
Published: (2019-06-01)

Regulating complement in the kidney: insights from CFHR5 nephropathy
by: Daniel P. Gale, et al.
Published: (2011-11-01)

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
by: Dana V. Rizk, et al.
Published: (2023-05-01)